Identify and analyze resistance mechanisms faster with our world-leading machine learning systems for sequence-based predictions of resistance.
“We are proud to have partnered with Shionogi to develop a sequence-based diagnostic model to predict susceptibility to the antibiotic cefiderocol.”
Dr. Paul A Rhodes, PhD
CEO & Chief Scientific Officer
NGD
From NGD’s October 2024 press release:
NGD has built methods and infrastructure to develop and validate whole genome sequencing-based machine learning models to determine antibiotic susceptibility in Gram-negative bacteria. NGD has demonstrated these models to be useful tools to show plausible potential resistance pathways, which can help guide healthcare professionals’ approach to antibiotic use.